Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05119_nanopub.RAj-C4J0DTlTej3WguE44JGRGjhxkLIcaQlkAq6L_3FUw#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05119 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05119 label "Rilapladib [drugbank:DB05119]" assertion.
- drugbank:DB05119 seeAlso DB05119 assertion.
- drugbank:DB05119 description "Rilapladib is the third genomics-derived small molecule drug arising from the Human Genome Sciences-GlaxoSmithKline collaboration to enter clinical development. It is a lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor. Lp-PLA2 is an enzyme associated with the formation of atherosclerotic plaques." assertion.
- drugbank:DB05119 identifier "drugbank:DB05119" assertion.
- drugbank:DB05119 title "Rilapladib" assertion.
- drugbank:DB05119 drugbank_vocabulary:x-cas cas:412950-08-4 assertion.
- drugbank:DB05119 drugbank_vocabulary:drugbank-id "DB05119" assertion.
- drugbank:DB05119 bio2rdf_vocabulary:x-identifiers.org DB05119 assertion.
- drugbank:DB05119 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05119" assertion.
- drugbank:DB05119 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05119 bio2rdf_vocabulary:identifier "DB05119" assertion.